The response of serum ghrelin and PYY to oral glucose and steamed-bread tolerance test in nonobese and obese patients with type 2 diabetes

Journal of Sichuan University (Medical Science)

Volumn 39, Issue 5, 2008, Pages 772-775

  An, Zhen Mei ^a   Zhang, Lin ^a   Zhang, Mei ^a   Huang, Ming Jie ^a   Xiong, Zhong Yun ^a   Zhang, Guo Fu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Ghrelin; Insulin sensitivity; PYY; Type 2 diabetes

Indexed keywords

EID: 53349168139     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in huma. J Clin Endocrinol Metab, 2001; 86(12): 5992-5995.
2. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature, 2000; 407(6806): 908-913.
3. Vrang N, Madsen AN, Tang-Christensen M, et al. PYY (3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol, 2006; 291(2): R367-375.
4. Boey D, Heilbronn L, Sainsbury A, et al. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides, 2006; 40: 317-324.
5. Kim BJ, Carlson OD, Jang HJ, et al. Peptide YY is secreted after oral glucose administration in aging individuals in a gender-specific manner. J Clin Endocrin Metab, 2005; 90(12): 6665-6671.
6. Bacha F, Arslanian SA. Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrin Metab, 2006; 91 (8): 3117-3122.
7. Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol, 2002; 56(2): 203-206.
8. Pöykkö SM, Kellokoski E, Hörrkkö S, et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a highfat diet. Diabetes, 2004; 53(8): 1949-1952.
9. Boey D, Lin S, Karl T, et al. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia, 2006; 49(6): 1360-1370.
10. Torekov SS, Larsen LH, Glümer C, et al. Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. Diabetes, 2005; 54(7):2261-2265.
11. Pöykkö SM, Kellokoski E, Hörkkö S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003; 52 (10): 2546-2553.